MOLECULAR TARGETUniProt: P42338
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
39 compounds · BiohacksAI corpus v20260307-01
39
compounds
Compounds
39
Gene Symbol
PIK3CB
NCBI Gene
5291
Looking for compounds that interact with PIK3CB?
View all 39 compounds →About PIK3CB
PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) is a biological target studied in biomedical research. The BiohacksAI corpus identifies 39 compounds with documented interactions with this target, based on BindingDB assay data and PubMed literature.
View PIK3CB on UniProt →Compounds Targeting PIK3CB (39)
1
Ly 294002
4.84
confidence
2
Dactolisib
4.25
confidence
3
Pi 103
4.17
confidence
4
Idelalisib
4.13
confidence
5
Zstk 474
3.56
confidence
6
Cgs 15943
3.47
confidence
7
Buparlisib
3.40
confidence
11
studies
3.26
confidence
9
Pictilisibdrugage
0
studies
3.14
confidence
10
Omipalisib
3.14
confidence
11
Lestaurtinib
3.04
confidence
12
Quisinostat
2.94
confidence
13
Ku 55933
2.94
confidence
14
Duvelisib
2.94
confidence
15
Fimepinostat
2.89
confidence
16
Apitolisib
2.71
confidence
227
studies
2.64
confidence
18
Pf 04691502
2.64
confidence
19
Sapanisertib
2.64
confidence
20
Gedatolisib
2.56
confidence
21
Vistusertib
2.48
confidence
22
Gsk 461364
2.40
confidence
23
Copanlisib
2.40
confidence
24
Azd 6482
2.30
confidence
25
Bimiralisib
2.30
confidence
26
Azd 7648
2.30
confidence
27
Vs 5584
2.30
confidence
28
Bgt 226 Free Base
2.20
confidence
29
Tg100 115
2.08
confidence
30
Elimusertib
2.08
confidence
31
Voxtalisib
2.08
confidence
32
Gsk 2636771
2.08
confidence
33
Gsk 1059615
1.95
confidence
34
Pilaralisib
1.95
confidence
35
Azd 8186
1.79
confidence
36
Eganelisib
1.79
confidence
300
studies
1.61
confidence
300
studies
0.69
confidence
298
studies
0.69
confidence
Top 39 compounds by confidence score. Derived from BindingDB assay data.
Data Source
Corpusv20260307-01
SourceBindingDB · ChEMBL · PubMed
All data is computationally derived from published research. Not medical advice. Independent validation required.